• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.

作者信息

Orf Katharine, Rogosic Srdan, Dexter Daniel, Ancliff Phil, Badle Saket, Brierley Joe, Cheng Danny, Dalton Caroline, Dixon Garth, Du Pré Pascale, Grandjean Louis, Ghorashian Sara, Mittal Prabal, O'Connor David, Pavasovic Vesna, Rao Anupama, Samarasinghe Sujith, Vora Ajay, Bamford Alasdair, Bartram Jack

机构信息

Department of Haematology, Great Ormond Street Hospital for Children NHS Trust, London, UK.

Paediatric Bioethics Centre, Great Ormond Street Hospital for Children NHS Trust, London, UK.

出版信息

Br J Haematol. 2020 Sep;190(5):e274-e276. doi: 10.1111/bjh.17014. Epub 2020 Aug 23.

DOI:10.1111/bjh.17014
PMID:32652563
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7404383/
Abstract
摘要

相似文献

1
Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.在新诊断的伴有SARS-CoV-2感染的小儿急性淋巴细胞白血病诱导化疗期间使用瑞德西韦。
Br J Haematol. 2020 Sep;190(5):e274-e276. doi: 10.1111/bjh.17014. Epub 2020 Aug 23.
2
BET 1: The role of remdesivir in COVID-19 infection.BET 1：瑞德西韦在 COVID-19 感染中的作用。
Emerg Med J. 2020 Aug;37(8):522-523. doi: 10.1136/emermed-2020-210336.02.
3
SARS-CoV-2 infection in children with febrile neutropenia.发热性中性粒细胞减少症患儿的新型冠状病毒2型感染
Ann Hematol. 2020 Aug;99(8):1941-1942. doi: 10.1007/s00277-020-04115-1. Epub 2020 Jun 12.
4
Liver injury in remdesivir-treated COVID-19 patients.接受瑞德西韦治疗的新冠肺炎患者的肝损伤
Hepatol Int. 2020 Sep;14(5):881-883. doi: 10.1007/s12072-020-10077-3. Epub 2020 Jul 28.
5
Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?我们用瑞德西韦（一种老药新包装）找到了治疗新冠病毒肺炎的万灵药了吗？
J R Coll Physicians Edinb. 2020 Jun;50(2):159-161. doi: 10.4997/JRCPE.2020.217.
6
Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial.评估静脉用瑞德西韦治疗成人重症 COVID-19 的疗效和安全性：一项 3 期随机、双盲、安慰剂对照、多中心试验的研究方案。
Trials. 2020 May 24;21(1):422. doi: 10.1186/s13063-020-04352-9.
7
[Remdesivir for patients with COVID-19].[瑞德西韦用于新型冠状病毒肺炎患者]
Internist (Berl). 2020 Aug;61(8):869-872. doi: 10.1007/s00108-020-00836-7.
8
Arguments in favour of remdesivir for treating SARS-CoV-2 infections.支持瑞德西韦治疗新型冠状病毒感染的论据。
Int J Antimicrob Agents. 2020 Apr;55(4):105933. doi: 10.1016/j.ijantimicag.2020.105933. Epub 2020 Mar 6.
9
Probable Molecular Mechanism of Remdesivir for the Treatment of COVID-19: Need to Know More.瑞德西韦治疗 COVID-19 的可能分子机制：需要了解更多。
Arch Med Res. 2020 Aug;51(6):585-586. doi: 10.1016/j.arcmed.2020.05.001. Epub 2020 May 12.
10
Delayed Initiation of Remdesivir in a COVID-19-Positive Patient.瑞德西韦治疗 COVID-19 阳性患者的时机延误。
Pharmacotherapy. 2020 Jun;40(6):592-598. doi: 10.1002/phar.2403. Epub 2020 May 20.

引用本文的文献

1
Unlocking the potential of remdesivir: innovative approaches to drug delivery.释放瑞德西韦的潜力：药物递送的创新方法。
Drug Deliv Transl Res. 2025 Apr 17. doi: 10.1007/s13346-025-01843-7.
2
Clinical Outcomes of Pediatric Cancer Patients with COVID-19: A Cross-Sectional Study.新冠肺炎患儿癌症患者的临床结局：一项横断面研究。
Int J Hematol Oncol Stem Cell Res. 2024 Oct 1;18(4):313-322. doi: 10.18502/ijhoscr.v18i4.16756.
3
COVID-19 infection in children with blood cancer: A systematic review.血癌患儿的新冠病毒感染：一项系统综述
Ann Hematol. 2025 Feb;104(2):1203-1230. doi: 10.1007/s00277-024-06057-4. Epub 2024 Nov 5.
4
Challenges in Treating Pediatric Cancer Patients during the COVID-19 Pandemic: Balancing Risks and Care.COVID-19 大流行期间治疗儿科癌症患者的挑战：平衡风险和护理。
Viruses. 2024 Apr 26;16(5):690. doi: 10.3390/v16050690.
5
Remdesivir: treatment of COVID-19 in special populations.瑞德西韦：特殊人群中新型冠状病毒肺炎的治疗
Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun;397(6):3829-3855. doi: 10.1007/s00210-023-02927-2. Epub 2024 Jan 5.
6
The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned.新冠疫情对儿童恶性肿瘤诊断与治疗的影响：虽非往昔，但收获经验。
Vaccines (Basel). 2023 Mar 15;11(3):667. doi: 10.3390/vaccines11030667.
7
Thrombocytopenia and clinical outcomes among patients with COVID-19 disease: A cohort study.新型冠状病毒肺炎患者的血小板减少症与临床结局：一项队列研究。
Health Sci Rep. 2023 Feb 13;6(2):e1111. doi: 10.1002/hsr2.1111. eCollection 2023 Feb.
8
Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey.血液系统恶性肿瘤与新冠同时发病：一项Epicovideha调查
Cancers (Basel). 2022 Nov 10;14(22):5530. doi: 10.3390/cancers14225530.
9
Remdesivir: the first FDA-approved anti-COVID-19 Treatment for Young Children.瑞德西韦：首个获美国食品药品监督管理局批准用于幼儿的抗新冠病毒治疗药物。
Discoveries (Craiova). 2022 Jun 30;10(2):e151. doi: 10.15190/d.2022.10. eCollection 2022 Apr-Jun.
10
Remdesivir and Its Combination With Repurposed Drugs as COVID-19 Therapeutics.瑞德西韦及其与再利用药物的联合应用作为 COVID-19 治疗药物。
Front Immunol. 2022 May 12;13:830990. doi: 10.3389/fimmu.2022.830990. eCollection 2022.

本文引用的文献

1
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.瑞德西韦治疗新冠病毒病-初步报告。回复。
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
2
Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status.儿童 COVID-19 患者不同严重程度和过敏状态的 182 例临床特征。
Allergy. 2021 Feb;76(2):510-532. doi: 10.1111/all.14452. Epub 2020 Sep 3.
3
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.瑞德西韦治疗重症 COVID-19 患者的 5 天与 10 天疗程比较
N Engl J Med. 2020 Nov 5;383(19):1827-1837. doi: 10.1056/NEJMoa2015301. Epub 2020 May 27.
4
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.瑞德西韦治疗成人重症 COVID-19 的随机、双盲、安慰剂对照、多中心临床试验。
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
5
COVID-19 infection in children and adolescents with cancer in Madrid.马德里癌症患儿及青少年的新冠病毒感染情况
Pediatr Blood Cancer. 2020 Jul;67(7):e28397. doi: 10.1002/pbc.28397. Epub 2020 May 8.
6
Cancer patients and research during COVID-19 pandemic: A systematic review of current evidence.癌症患者和 COVID-19 大流行期间的研究：当前证据的系统评价。
Crit Rev Oncol Hematol. 2020 Jun;150:102972. doi: 10.1016/j.critrevonc.2020.102972. Epub 2020 Apr 22.
7
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2.多中心关于儿童 2019 冠状病毒病/严重急性呼吸综合征冠状病毒 2 抗病毒药物使用的初始指导意见
J Pediatric Infect Dis Soc. 2020 Dec 31;9(6):701-715. doi: 10.1093/jpids/piaa045.
8
Lessons after the early management of the COVID-19 outbreak in a pediatric transplant and hemato-oncology center embedded within a COVID-19 dedicated hospital in Lombardia, Italy. Estote parati.意大利伦巴第大区一家 COVID-19 定点医院内的儿科移植和血液肿瘤科在 COVID-19 早期管理中的经验教训。Estote parati.
Bone Marrow Transplant. 2020 Oct;55(10):1900-1905. doi: 10.1038/s41409-020-0895-4. Epub 2020 Apr 20.
9
Compassionate Use of Remdesivir for Patients with Severe Covid-19.瑞德西韦在治疗重症 COVID-19 患者中的同情使用。
N Engl J Med. 2020 Jun 11;382(24):2327-2336. doi: 10.1056/NEJMoa2007016. Epub 2020 Apr 10.
10
SARS-CoV-2 Infection in Children.儿童感染新型冠状病毒2型
N Engl J Med. 2020 Apr 23;382(17):1663-1665. doi: 10.1056/NEJMc2005073. Epub 2020 Mar 18.